StockData
Renalytix plc logo

Renalytix plc (RNLXY) stock

RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF
Financials through Q1 FY2025, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)

Close on Oct 19, 2026Market cap $375.75MP/E –Yield –

Renalytix price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Renalytix's price to sales ratio was 250.8× on Oct 19, 2026.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 2026250.8×−4.6
2025Dec 31, 2025255.4×–

More Renalytix figures

See a number that looks wrong?